While semaglutide and other GLP-1s are already available for diabetes and other conditions, the version of semaglutide being tested in clinical trials is not yet approved for treatment of Alzheimer's disease
Cell metabolism , 27 (4), 740-756
[108] Dimitriadis GD, Maratou E, Kountouri A, Board M, Lambadiari V
Debe sospecharse un cuadro de pancreatitis en pacientes con dolor abdominal intenso persistente (con o sin nuseas), y los agonistas de los receptores de GLP-1 deben suspenderse en tales pacientes
After 40 weeks, 78% to 85% of adults taking Mounjaro achieved an HbA1c below 7%, compared with 23% of adults taking a placebo
More than this will lead to rebound headache (medication overuse headache) , and episodic migraine will eventually transform to chronic migraine